Previous 10 | Next 10 |
2023-08-09 09:53:00 ET Alzheimer's patients could soon have more treatment options available. Biogen 's Leqembi obtained approval from the U.S. Food and Drug Administration earlier this year, and another treatment from Eli Lilly , donanemab, may not be far behind. The one drawba...
Inflammation Marker Signifies Increased Mortality Risk, Finds New Study in PLOS ONE PR Newswire Ten-fold increase in death risk in individuals with high levels of myeloperoxidase, or MPO, compared to those with low levels, according to analysis of 3,700 patients of M...
Quest Introduces First-To-Market Consumer-Initiated Blood Test for Alzheimer's Disease Risk Assessment on questhealth.com PR Newswire AD-Detect ™ Test for Alzheimer's Disease is the first blood-based biomarker test for assessing beta amyloid protein, a recognize...
2023-07-26 13:36:06 ET Quest Diagnostics, Inc. (DGX) Q2 2023 Earnings Conference Call July 26, 2023, 08:30 ET Company Participants Shawn Bevec - VP, IR James Davis - Chairman, CEO & President Sam Samad - EVP & CFO Conference Call Participants ...
2023-07-26 06:47:27 ET Quest Diagnostics press release ( NYSE: DGX ): Q2 Non-GAAP EPS of $2.30 beats by $0.04 . Revenue of $2.34B (-4.7% Y/Y) beats by $90M . Second quarter base business revenues of $2.30 billion, up 9.5% from 2022 Full year 2023 revenues n...
Quest Diagnostics Reports Second Quarter 2023 Financial Results; Updates Guidance for Full Year 2023 PR Newswire Second quarter revenues of $2.34 billion , down 4.7% from 2022 Second quarter reported diluted earnings per share ("EPS") of $2.05 , up 4.6% from 2022; ...
2023-07-25 11:31:41 ET Quest Diagnostics ( NYSE: DGX ) is scheduled to announce Q2 earnings results on Wednesday, July 26th, before market open. The consensus EPS Estimate is $2.26 (-4.2% Y/Y) and the consensus Revenue Estimate is $2.25B (-8.2% Y/Y). Over the last 2 ye...
2023-07-25 10:52:39 ET Major earnings expected before the bell on Wednesday include: The Boeing ( BA ) GSK ( GSK ) The Coca-Cola ( KO ) AT&T ( T ) Tilray Brands ( TLRY ) Other earnings slated for release before Wednesday's open include: ...
2023-07-23 07:50:02 ET Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. Introduction The D...
2023-07-21 08:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
News, Short Squeeze, Breakout and More Instantly...
Quest Diagnostics Incorporated Company Name:
DGX Stock Symbol:
NYSE Market:
Quest Diagnostics Incorporated Website:
Haystack Oncology and Université de Montréal's affiliated hospital research centre, the CRCHUM, to Deploy Haystack MRD™ Technology in Research Study for Metastatic Colorectal Cancer PR Newswire BALTIMORE, Md. and MONTREAL , July 29, 2024 /PRN...
BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases PR Newswire Collaboration on Flow Cytometry-Based Companion Diagnostics to Advance Personalized Health Care FRANKLIN LAKES, N.J. and SECAUCUS, N.J. , July 25, 20...
2024-07-24 07:00:10 ET Eric Coldwell from Robert W. Baird issued a price target of $154.00 for DGX on 2024-07-24 06:36:00. The adjusted price target was set to $154.00. At the time of the announcement, DGX was trading at $140.96. The overall price target consensus is at ...